Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Anemia, Sickle Cell × maltodextrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Vaso-Occlusive Crises 1 Head and Neck Neoplasms 1 Anemia, Sickle Cell 1

Interventions

voxelotor 1 maltodextrin 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Peripheral Blood Stem Cell Transplantation 1 Glutamine 1 Cyclophosphamide 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Emmaus Medical, Inc.

Phase 3 Completed

230 enrolled 19 charts 1 FDA

Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡